LINCOLN
Pharmaceuticals & Drugs
₹381.45
0.00 (0.00%)
Market Cap | 755 Cr | EPS | 36.4 | High | 383.6 | ||
Stock P/E | 10.4 | Net Profit Margin | 11.2 | Low | 371 |
Performance
Today’s Low
Today’s High
371
383.6
52W Low
52W High
270
456.3
Open Price | 379.3 | Volume | 372 |
Prev. Close | 376.75 |
Fundamentals
Market Cap | 755 Cr | ROE | 17.4% | ||
P/E Ratio(TTM) | 10.4 | EPS(TTM) | 0.0 | ||
P/B Ratio | 1.5 | Dividend Yield | 0.4% | ||
Industry P/E | 60.4 | Book Value | 250.9 | ||
Face Value | 10.0 |
About the Company
Lincoln Pharmaceuticals was established in 1979 to manufacture and market affordable therapeutic products. Since then, Lincoln Pharmaceuticals has come a long way.
Lincoln Pharmaceuticals is a public limited company with a large shareholder base including members of the medical fraternity. It has its own manufacturing facilities, covering all the major dosage forms, like tablets, capsules, injectables, syrups, Ointments, etc. Its present manufacturing activities are located near Ahmedabad. The plant spreads across 30,000 square meters. There are three different buildings for tablets, capsules and injectables and also a separate building for quality control.
An ultramodern laboratory with state-of-the-art equipments ensures in-house quality assurance of each of the products. The products are designed for all therapeutic segments with a special emphasis on gynecological and orthopedic specialties.
Group of Companies
- Lincoln Parenterals
- Karnavati Distributors
- Down Town Travels
- Shelavi Paper Mills
Product of the company
- Tablets
- Capsules
- Injectables
- Syrups
- Ointments
Certification
- WHO-GMP standard
- ISO 9002 certification
- Export House certification
Parent Organization | Lincoln Pharmaceuticals Ltd. | Managing Director | Mahendra G Patel | ||
Founded | 1995 | NSE Symbol | LINCOLN |
Financials
All values are in Rs Cr
Shareholding Pattern
Promoters
42.05%
Mutual Funds
0.00%
Foreign Institutions
0.77%
Domestic Institutions
0.00%
Promoters
42.05%
Mutual Funds
0.00%
Foreign Institutions
0.77%
Domestic Institutions
0.00%
Promoters
42.05%
Mutual Funds
0.00%
Foreign Institutions
0.77%
Domestic Institutions
0.00%
Promoters
42.05%
Mutual Funds
0.00%
Foreign Institutions
0.77%
Domestic Institutions
0.00%
Promoters
42.05%
Mutual Funds
0.00%
Foreign Institutions
0.77%
Domestic Institutions
0.00%
Peer Comparison
Company | 52 Week | Market Price | P/E Ratio | Financials | Share Holding |
---|---|---|---|---|---|
381.45(1.2%) | 10.4 | ||||
121.35(-0.5%) | 0.0 | ||||
91.05(0.9%) | 187.6 | ||||
305.55(-0.1%) | 116.8 |